Clinical Trial Update: A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating decitabine in relapsed or refractory T-lymphoblastic lymphoma is ongoing; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-lymphoblastic Lymphoma

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Mingzhi Zhang | Conditions: T-lymphoblastic Lymphoma | Phase 4 | Status: UNKNOWN